Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126821371 | 12682137 | 1 | I | 20160218 | 20160219 | 20160824 | 20160824 | PER | US-JUBILANT HOLLISTERSTIER LLC-1056723 | JUBILANT | 20.00 | YR | M | Y | 0.00000 | 20160824 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126821371 | 12682137 | 1 | PS | MOLDS, RUSTS AND SMUTS, CANDIDA ALBICANS | CANDIDA ALBICANS | 1 | IRRIGATION | U | E1502044 09/13/2018 | 103888 | |||||||||
126821371 | 12682137 | 2 | SS | LIDOCAINE. | LIDOCAINE | 1 | IRRIGATION | U | 0 | ||||||||||
126821371 | 12682137 | 3 | C | CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 4 | C | METHYLPHENIDATE. | METHYLPHENIDATE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 5 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 7 | C | CIMETIDINE | CIMETIDINE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 8 | C | GUANFACINE. | GUANFACINE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 9 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 10 | C | DUAC | BENZOYL PEROXIDECLINDAMYCIN PHOSPHATE | 1 | Topical | 0 | |||||||||||
126821371 | 12682137 | 11 | C | TAZORAC | TAZAROTENE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 12 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 13 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 14 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 15 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 16 | C | Calcium with Vitamin D | CALCIUMVITAMIN D | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 17 | C | ALBUTEROL. | ALBUTEROL | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 18 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 19 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 20 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 0 | |||||||||||
126821371 | 12682137 | 21 | C | LIDOCAINE. | LIDOCAINE | 1 | Topical | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126821371 | 12682137 | 1 | Off label use |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126821371 | 12682137 | Erythema | |
126821371 | 12682137 | Injection site discomfort | |
126821371 | 12682137 | Swelling | |
126821371 | 12682137 | Tenderness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126821371 | 12682137 | 1 | 20160218 | 20160218 | 0 | |
126821371 | 12682137 | 2 | 20160218 | 20160218 | 0 |